Celltrion, Inc. (KRX:068270)
203,500
-5,500 (-2.63%)
Last updated: Mar 12, 2026, 12:30 PM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 45.75 trillion as of March 11, 2026. Its market cap has increased by 18.25% in one year.
Market Cap
45.75T
Enterprise Value
47.83T
Revenue
3.90T
Ranking
n/a
PE Ratio
63.08
Stock Price
203,500.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 45.75T, an increase of 43,970.72%. That is a compound annual growth rate of 41.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 45.09T | 13.86% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.70T |
| ALTEOGEN | 20.08T |
| SK Biopharmaceuticals | 7.73T |
| Peptron | 6.74T |
| LigaChem Biosciences | 6.54T |
| HLB Co., Ltd. | 6.46T |
| Voronoi | 5.92T |
| OliX Pharmaceuticals | 3.63T |